Sign up to save your podcasts
Or
Share How Amicus Embedded Patient Advocacy into its Corporate DNA
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
How Amicus Embedded Patient Advocacy into its Corporate DNA
About this podcast:
In this keynote from Patients as Partners in Clinical Research 2025, Amicus Therapeutics' Chief Patient Advocate, Jayne Gershkowitz, shares how their organization established and embedded patient advocacy into their core structure for lasting impact.
More specifically, Ms Gershkowitz focuses on:
In this keynote from Patients as Partners in Clinical Research 2025, Amicus Therapeutics' Chief Patient Advocate, Jayne Gershkowitz, shares how their organization established and embedded patient advocacy into their core structure for lasting impact.
More specifically, Ms Gershkowitz focuses on:
- Defining role standards and recruiting the right talent
- Co-creatin research with patient communities and developing patient-centered outcomes
- Generating metrics that demonstrate the impact on R&D
View all episodes
By Conference ForumAbout this podcast:
In this keynote from Patients as Partners in Clinical Research 2025, Amicus Therapeutics' Chief Patient Advocate, Jayne Gershkowitz, shares how their organization established and embedded patient advocacy into their core structure for lasting impact.
More specifically, Ms Gershkowitz focuses on:
In this keynote from Patients as Partners in Clinical Research 2025, Amicus Therapeutics' Chief Patient Advocate, Jayne Gershkowitz, shares how their organization established and embedded patient advocacy into their core structure for lasting impact.
More specifically, Ms Gershkowitz focuses on:
- Defining role standards and recruiting the right talent
- Co-creatin research with patient communities and developing patient-centered outcomes
- Generating metrics that demonstrate the impact on R&D